OpenAI's new GPT-5.5-Cyber tops Claude Mythos 5 in vulnerability benchmark0 0

OpenAI is rolling out the full, limited-release version of GPT-5.5-Cyber—a specialized AI model that outperforms its ...
The Hacker News

OpenAI Expands Daybreak With GPT-5.5-Cyber to Help Defenders Patch Security Flaws

OpenAI on Monday said it's releasing an improved version of its GPT‑5.5‑Cyber model to trusted defenders as part of the Daybreak initiative the artificial intelligence (AI) company announced last ...

I've reviewed every PDF editor out there - then I had ChatGPT build me a better one

The smartest way to use AI may not be letting it interact with your files, but asking it to write software that handles them ...
Forbes

Generate Biomedicines IPO Turns Heads

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Pills, tablets and capsules on world map with charts blue background. International ...
Reuters

Generate Biomedicines shares fall in weak Nasdaq debut for drug developer

Feb 27 (Reuters) - Flagship-backed Generate Biomedicines' shares fell more than 6% in their Nasdaq debut on Friday, giving the drug developer a valuation of $1.91 billion, as lingering market ...
MedCity News

Generate Biomedicines’ IPO Brings In $400M for Pivotal Tests of Severe Asthma Drug

Despite wide availability of biologic drugs for asthma, use of these injectable medicines remains low — patients just dislike frequent injections. Generate Biomedicine’s lead drug candidate could ...
FierceBiotech

Behind Generate's 'feverish' race to raise $400M IPO while window remains open

Generate:Biomedicines has earmarked $300 million of its IPO funds to complete a pair of phase 3 asthma trials for its anti-TSLP antibody GB-0895. (Fabrice Cabaud/Stock/Getty Images Plus) ...
Reuters

Drug developer Generate Biomedicines raises $400 million in US IPO

Feb 26 (Reuters) - Generate Biomedicines said on Thursday that it raised $400 million in its U.S. initial public offering, pricing shares of the U.S.-based drug developer at $16 each. The offering ...
Seeking Alpha

Generate Biomedicines Begins IPO Push With Major Collaboration Deals

Generate Biomedicines, Inc. (GENB) has filed to raise public capital in an IPO to advance its pipeline of treatment candidates, according to an SEC filing. The company is developing treatments for ...
Bloomberg L.P.

Flagship-Backed Drug Firm Generate Biomedicines Files for US IPO

Generate Biomedicines Inc. filed for an initial public offering, joining a growing list of biotechnology firms to leap to public markets as investors embrace the sector. The Somerville, ...
InfoWorld

How to generate C-like programs with Python

You might be familiar with how Python and C can work together, by way of projects like Cython. The new PythoC project has a unique twist on working with both languages: it lets you write ...
InfoWorld

PythoC: A new way to generate C code from Python

PythoC lets you use Python as a C code generator, but with more features and flexibility than Cython provides. Here’s a first look at the new C code generator for Python. Python and C share more than ...